Clinical Trial Update: Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Descartes-08 CAR-T cells in generalized myasthenia gravis. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis Generalized

Drugs mentioned

• Descartes-08 CAR-T Cells

Snippet

Sponsor: Cartesian Therapeutics | Conditions: Myasthenia Gravis, Generalized | Phase 2 | Status: ACTIVE_NOT_RECRUITING